Author · brief 2026-08-16

@MisterInversor MisterInversor

Spanish-language perma-bull preaching an AI-plus-biology-plus-Bitcoin secular wealth revolution

Original retail-facing analyst running a high-conviction, lo

trader score
+0.71
hit rate
55%
mean α
+0.58%
signals 14d
121

Grade = how their written analysis reads (A best). Trader score = how their last-20 timestamped calls performed vs SPY. · Analyst brief as of 2026-08-16.

Their picks, scored

Across their last 20 scored bets: 55% hit rate, +0.58% mean alpha, trader score +0.71. Their last-14d mentions, direction-adjusted, have moved +2.0% since posting (mean over 106 mentions with price data).

HIMS dominates as DUOL and thematic longs reinforce aggressive growth

The author owns a highly concentrated AI-and-longevity basket spanning HIMS, DUOL, TSLA, PLTR, AMD, and IBRX, with HIMS clearly dominating attention. Their distinctive view is that HIMS can become a $500 billion company and DUOL can reach the same valuation by 2035; post-earnings HIMS conviction rose sharply, including a stated willingness to add repeatedly at $15.

Disclosed book4names the author says they hold — positions, not commentary
LONGHIMS44 sigsLONGDUOL37 sigsLONGTSLA9 sigsLONGIBRX3 sigs
Themes3analyst read · 2026-08-16
HIMS growth reacceleration and platform investment
bullconsistent46 signals
⚠ 96% of theme signals are HIMS — flag pump risk
DUOL user scaling and valuation upside
bullfading37 signals
⚠ 100% of theme signals are DUOL — flag pump risk
Concentrated AI and longevity optionality basket
bullfading116 signals
Hypotheses10what the author said, ticker-anchored — ✓ skin = disclosed position behind it
claimtickerdirstrengthsignalsskinthemereceipt
DUOL is among the market's best mid-cap AI risk-reward opportunities.DUOL0.722DUOL user scaling and valuation
DUOL is a high-conviction AI holding with exceptional long-term growth potential.DUOL0.693Concentrated AI and longevity op
HIMS is a core AI-and-longevity holding with unusually attractive mid-cap risk-reward.HIMS0.463Concentrated AI and longevity op
TSLA is a major portfolio holding whose long-term optionality can justify its current valuation.TSLA0.412Concentrated AI and longevity op
DUOL could reach a $500 billion valuation by 2035 given its market and growth potential.DUOL0.312DUOL user scaling and valuation
HIMS revenue and subscriber growth are reaccelerating, with second-quarter results exceeding expectations.HIMS0.256HIMS growth reacceleration and p
DUOL has substantial valuation upside if daily active users reach 100 million by 2028.DUOL0.172DUOL user scaling and valuation
Higher AI, R&D, and peptide investment expands HIMS long-term opportunity despite near-term costs.HIMS0.163HIMS growth reacceleration and p
HIMS merits roughly $70 now and could ultimately become a $500 billion company.HIMS0.126HIMS growth reacceleration and p
HIMS has an Amazon-like trajectory, with the earlier Amazon comparison potentially understating its upside.HIMS0.034HIMS growth reacceleration and p
Direction this week

HIMS conviction intensified after earnings through escalating $70 and $500 billion valuation claims, followed by an explicit plan to add repeatedly at $15. DUOL conviction remained consistently bullish, while the midweek portfolio disclosure surfaced extreme AI-and-longevity concentration; no trims, exits, or bearish flips appeared. HIMS represents 92% of its main theme's signals, creating clear concentration and pump-risk.

Per-ticker coverage13positions first, then by signal count
tickersignalssentimentcallsposnewsactionalignment
HIMS44+0.66213long call✓ long (has position)
DUOL37+0.57212long call✓ long (has position)
TSLA9+0.65010hold disclosed✓ long (has position)
IBRX3+0.68011hold disclosed✓ long (has position)
PLTR13+0.63001bullish commentarycommentary only
AMD10+0.64001bullish commentarycommentary only
AMZN2+0.25000neutral commentaryneutral
SPCX2+0.70101long callno position bull call
NVO1+0.55000bullish commentarycommentary only
IREN1+0.55000bullish commentarycommentary only
ABCL1+0.60001bullish commentarycommentary only
CRSP1+0.70001bullish commentarycommentary only
CIFR1+0.65000bullish commentarycommentary only

Alignment separates skin-in-the-game from commentary: ✓ = the author discloses a position consistent with their talk; “call (no pos)” = directional call without a disclosed position; “commentary” = opinion only.

Conviction trades2explicit CALL_DIRECTIONAL actions, receipts included

add 1

datetickerwhat they saidreceipt
2026-08-11HIMSWants to buy HIMS repeatedly if shares return to $15.

initiate long 1

datetickerwhat they saidreceipt
2026-08-08SPCXWould add SpaceX as the sole desired portfolio addition if valuation becomes attractive.
Position disclosures5skin in the game
HIMS Disclosed HIMS within an extremely concentrated AI-and-longevity portfolio. unclear
DUOL Disclosed DUOL within an extremely concentrated AI-and-longevity portfolio. unclear
TSLA Disclosed TSLA within an extremely concentrated AI-and-longevity portfolio. unclear
PLTR Disclosed PLTR within an extremely concentrated AI-and-longevity portfolio. unclear
AMD Disclosed AMD within an extremely concentrated AI-and-longevity portfolio. unclear
News / data points4discrete events + data the author reported
ABCL ABCL gained more than 35% following positive Phase 2 ABCL635 trial results.
HIMS Second-quarter revenue and EBITDA beat estimates while EPS missed.
HIMS HIMS beat revenue expectations, accelerated subscriber growth, and raised 2026 guidance.
HIMS HIMS delivered a large revenue beat and record subscriber growth.
Best hypotheses5their highest-scoring claims in our index
Depressed valuation, improving fundamentals, and strong cash generation create an attractive long-term accumulation oppo
bullHIGH8 co-supporters
Growth in TEM's clinical reach, proprietary healthcare data, licensing, and oncology businesses supports a broader long-
bullHIGH5 co-supporters
Reaccelerating daily users, engagement, and retention show DUOL's growth engine remains healthy despite fears of post-ea
bullHIGH7 co-supporters
Tempus's definitive acquisition establishes $16.25 per share as PSNL's transaction value through primarily stock conside
bullHIGH27 co-supporters
Revenue reacceleration and raised 2026 guidance confirm that HIMS has resumed durable top-line growth despite the mixed
bullHIGH6 co-supporters
Recent signals15receipts included
date (PT)tickerauthorsentwhat they saidsince thenreceipt
2026-08-28·@MisterInversor·States that every market decline is a long-term opportunity.·
2026-08-28AMD@MisterInversor+0.70Argues AMD is building network effects that AI-era businesses will need.
2026-08-28AMD@MisterInversor+0.80Forecasts accelerating AMD CPU and GPU demand over the next two to three years.
2026-08-27META@MisterInversor+0.15Argues AMD is becoming a neutral all-in-one AI platform through acquisitions, agreements and heterogeneous architecture.+1.2%
2026-08-27GOOG@MisterInversor+0.15Argues AMD is becoming a neutral all-in-one AI platform through acquisitions, agreements and heterogeneous architecture.+1.5%
2026-08-27CBRS@MisterInversor+0.15Argues AMD is becoming a neutral all-in-one AI platform through acquisitions, agreements and heterogeneous architecture.·
2026-08-27AMD@MisterInversor+0.75Argues AMD is becoming a neutral all-in-one AI platform through acquisitions, agreements and heterogeneous architecture.-2.3%
2026-08-27AMD@MisterInversor-0.10Reports AMD acquired specialized AI-inference chip company Taalas during the current month.-2.3%
2026-08-27MSTR@MisterInversor+0.55Celebrates Bitcoin reclaiming $80,000 and raises the prospect of new highs.-7.3%
2026-08-27ASST@MisterInversor+0.45Celebrates Bitcoin reclaiming $80,000 and raises the prospect of new highs.-6.0%
2026-08-27BTC@MisterInversor+0.75Celebrates Bitcoin reclaiming $80,000 and raises the prospect of new highs.·
2026-08-27·@MisterInversor·Frames diversification versus concentration as a function of horizon and risk tolerance.·
2026-08-26CRSP@MisterInversor+0.05Characterizes CRSP as very high risk with substantial theoretical upside.-2.5%
2026-08-26TSLA@MisterInversor+0.75Argues Tesla is significantly undervalued when viewed over the long term.+0.8%
2026-08-25BTC@MisterInversor+0.20Says ASST has regained portfolio weight through appreciation, nearly doubling in recent days.·

Grade is our human read-worthiness rating; trader score is a rolling 20-bet hit-rate/alpha composite — different things, often disagreeing. “Since then” is direction-unaware in the table; the summary line above adjusts for which way they leaned.